Hiệu suất
Tất cả

16.93%2026
2026
33.45%2025
2025
15.45%2024
2024
49.82%2023
2023
-31.30%2022
2022
10.47%2021
2021
46.62%2020
2020
22.65%2019
2019
49.8%0%-49.8%
Simone Rizzetto
📊 PORTFOLIO UPDATE 🚀 YTD +20.29%, September +0.64% so far. Macro backdrop: US-Iran hostilities reignited (Iran struck two US bases in Jordan, the US hit Iranian positions in the Gulf), Brent is above $90, the 10-year Treasury yield is around 4.8%, its highest since early 2025, and after Warsh's... Xem thêm Dịch
Simone Rizzetto
Simone Rizzetto đã chia sẻ bài đăng qua Peter Guenther
Vương quốc Anh
Thanks to @PGuenther for performing this analysis. It is great to see other PImore focused on risk-adjusted return rather than raw profits. $SPX500 Dịch
Peter Guenther
Peter Guenther
Vương quốc Anh
Community: A higher return with less risk is preferred. The chart update shows the risk/return profiles of the top-50 most copied Popular Investors (PIs). Portfolios at or close to the diagonal offer a fair deal. Portfolios above the diagonal are 'beating the odds' as they generate a higher return... Xem thêm Dịch
Simone Rizzetto
📊 PORTFOLIO UPDATE 🚀 YTD +19.78%, August +4.50%. 📌 Cancer Vaccines ➤ $BNTX (BioNTech SE-ADR): on Aug 28 the company terminated the Phase 2 trial of autogene cevumeran, its personalized mRNA cancer vaccine for advanced colorectal cancer (the program built with Roche). Shares fell ~8.4% to $102.08... Xem thêm Dịch
Simone Rizzetto
📊 PORTFOLIO UPDATE: Melanoma Vaccine Breakthrough, and Alibaba's AI Cash Grab🚀 YTD +21.60%, August +6.08%. Portfolio extending the lead while volatility rose elsewhere. Beating $NSDQ100 by 5%, and almost 2x profit compare to $SPX500 while keeping lower volatility. Three big stories: Moderna's... Xem thêm Dịch
Simone Rizzetto
In 2021 I wrote this post about cancer vaccines. Unfortunately eToro doesn't archive posts for this long, so I copy here again. It is still very actual and help you to understand better $MRNA (Moderna Inc) neo antigen vaccine. === ORIGINAL POST === 𝐓𝐡𝐞 𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐜𝐚𝐧𝐜𝐞𝐫 𝘃𝗮𝗰𝗰𝗶𝗻𝗲𝘀 The... Xem thêm Dịch
Simone Rizzetto
Breaking news! $MRNA (Moderna Inc) jumped nearly 100% premarket! $MRNA and $MRK (Merck & Co.) today announced positive topline results from the Phase 3 INTerpath-001 trial evaluating adjuvant treatment with intismeran autogene, a novel investigational mRNA-based individualized neoantigen therapy... Xem thêm Dịch
Simone Rizzetto
📊 PORTFOLIO UPDATE: Jobs Shock, Biotech strong earnings 🚀 YTD +18.00%, August MTD +2.95%. The weak US jobs report on August 7 was the defining data release of the week. The economy lost 23,000 jobs in July, well below expectations. 📌 Pharma: Merger Drama, Earnings Beats, and Pipeline Progress ➤... Xem thêm Dịch
Simone Rizzetto
📊 PORTFOLIO UPDATE: Earnings & Pharma Merger Shocks 🚀 YTD +14.64%, July finished with +2.08%. August already positive. One week since the last update. Pharma got shaken by a surprise merger report. Earnings were mixed. 📌 AI and Semiconductors: Earnings Deliver ➤ $MSFT (Microsoft): Another... Xem thêm Dịch
Simone Rizzetto
📊 PORTFOLIO UPDATE: Fed Showdown, Oil Chaos, and Earnings Week 🚀 Portfolio is still slightly up for the month. YTD +12.66%, MTD +0.33%. Very little volatility compared to $NSDQ100 US-Iran hostilities sent oil to $100/barrel before an abrupt ceasefire sent it down by 8%. 📌 Macro: Oil Whipsaw... Xem thêm Dịch
Simone Rizzetto
📊 PORTFOLIO UPDATE: Earnings Avalanche, FDA Breakthroughs, and AI Wars 🚀 One week since the last update and we entered the busiest earnings window of the quarter. Portfolio is stable. YTD +13.33%, MTD +0.93%. 📌 Pharma: Lipfendra Approval ➤ $MRK (Merck & Co.): FDA approved Lipfendra on July 16,... Xem thêm Dịch

Giới thiệu Simone Rizzetto
Ý
Chiến lược: Đa chiến lược

Scientist and MedTech+Healthcare investor with 10 years of experience in this industry.
Hiện tiểu sử đầy đủ Dịch
1.7K Người sao chép
47.1K Người theo dõi